Dysregulation of microRNA expression in the skin during cutaneous adverse drug reactions
- 1 December 2020
- Vol. 75 (12), 3279-3283
- https://doi.org/10.1111/all.14464
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Overexpression of cytotoxic proteins correlates with liver function impairment in patients with drug reaction with eosinophilia and systemic symptoms (DRESS)European Journal of Dermatology, 2018
- Overlap between maculopapular exanthema and drug reaction with eosinophilia and systemic symptoms among cutaneous adverse drug reactions in a dermatology wardBritish Journal of Dermatology, 2016
- Serum miR-124 up-regulation as a disease marker of toxic epidermal necrolysisEuropean Journal of Dermatology, 2015
- Human herpes virus reactivations and dynamic cytokine profiles in patients with cutaneous adverse drug reactions – a prospective comparative studyAllergy, 2015
- Upregulation of miR-18a-5p contributes to epidermal necrolysis in severe drug eruptionsJournal of Allergy and Clinical Immunology, 2014
- Increased ratio of FoxP3+ regulatory T cells/CD3+ T cells in skin lesions in drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptomsClinical and Experimental Dermatology, 2014
- Diagnostic, functional, and therapeutic roles of microRNA in allergic diseasesJournal of Allergy and Clinical Immunology, 2013
- Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?British Journal of Dermatology, 2007
- Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?British Journal of Dermatology, 2006